Credit: Getty Images. The resubmitted NDA was in response to a Complete Response Letter issued by the FDA in December 2021. The Food and Drug Administration (FDA) has accepted the resubmitted New Drug ...

Pennsylvania prisons now give suboxone to thousands of inmates with a substance abuse history, with thousands more on the waiting list. It's costing taxpayers tens of millions of dollars and raising ...

These are common-sense steps that will be good for orphan drug policy, good for public health, and good for the millions of Americans with opioid use disorder. In a previous post, we described an ...

LUND, Sweden, June 25, 2024 /PRNewswire/ -- Camurus (NASDAQ STO: CAMX) today announced the publication in JAMA Network Open of a new post hoc analysis from a 24-week randomized, double-blind, Phase 3 ...

SLOUGH, England and RICHMOND, Va., Dec. 2, 2019 /PRNewswire/ -- Indivior PLC (LON: INDV) announced today that new analysis from a 12-month investigation of monthly buprenorphine extended-release ...

Please provide your email address to receive an email when new articles are posted on . Brixadi is the first long-acting buprenorphine injectable that is available in weekly and monthly doses.

The trial, published in JAMA Internal Medicine, showed that mothers using the extended-release injection had higher rates of staying off illicit opioids compared to those taking daily sublingual ...